Sun Pharmaceuticals reported INR117.59B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Bharat Petroleum INR 16.4B 181.83B Jun/2026
Cipla INR 44.1B 5B Jun/2026
Dr.Reddys Laboratories INR 41.78B 4.02B Jun/2026
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Sh Fosun Pharma CNY 6.69B 1.9B Dec/2025
Sun Pharmaceuticals INR 117.59B 7.65B Mar/2026
UPL INR 82.12B 26.16B Mar/2026